Live Breaking News & Updates on Prnewswire Biosion United States Inc

Stay updated with breaking news from Prnewswire biosion united states inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT)

/PRNewswire/ Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced the phase 2 study initiation for the evaluation. ....

Hughm Davis , Prnewswire Biosion United States Inc , Biosion Inc , United States , Development Officer , Biosion United ,

Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis

/PRNewswire/ Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced that it has successfully opened an IND. ....

Hugh Davis , Prnewswire Biosion United States Inc , Drug Administration , Biosion Inc , United States , Chief Operating Officer , Biosion United ,